Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Contrarian Investing -- Ignore unavailable to you. Want to Upgrade?

To: pcyhuang who wrote (357)	9/26/2006 2:20:38 AM
From: Johnny Canuck	Read Replies (3) \| Respond to of 4080

I still thnk there are a lot of questions about the management of BVF. They were caught up in an insider trading scandal about 20 months ago and management managed to ride it out. The same guys are in control. It is seeing more competition on its generic drugs and it own new drug are only starting to get traction. I have not kept track recently, but I think it is not meeting the projections analysis are expecting. TEVA may be a better generic drug company. To be honest I don't know much about its drug pipeline.